US20140269216A1 - Method to allow for linking temporal record with physiological measurement in buttonless physiological meters - Google Patents
Method to allow for linking temporal record with physiological measurement in buttonless physiological meters Download PDFInfo
- Publication number
- US20140269216A1 US20140269216A1 US13/827,296 US201313827296A US2014269216A1 US 20140269216 A1 US20140269216 A1 US 20140269216A1 US 201313827296 A US201313827296 A US 201313827296A US 2014269216 A1 US2014269216 A1 US 2014269216A1
- Authority
- US
- United States
- Prior art keywords
- clock
- meter
- physiological
- measurement
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
- G01N33/48792—Data management, e.g. communication with processing unit
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
- G01N2035/00099—Characterised by type of test elements
- G01N2035/00108—Test strips, e.g. paper
Definitions
- Physiological measurements can be performed with a wide variety of known physiological measurement devices. For example, body temperature, cardiac rhythm, blood pressure, oxygen saturation in blood, electrocardiography, EEG, pulse, skin conductance, total hemoglobin, carboxyhemoglobin, methemoglobin, perfusion index and the like can be monitored with small handheld instrument or meter. Similarly, physiological measurements can be made of analytes (glucose, ketone, cholesterol and the like) present in physiological fluids, e.g. blood, blood derived products, or other fluids in biological systems. Physiological detection find use in a variety of applications, including clinical laboratory testing, home testing, hospitals, clinical, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions.
- glucose monitoring is one technique to ensure normal glycemic state of such person.
- the accuracy of such monitoring can significantly affect the health and ultimately the quality of life of the person with diabetes.
- a diabetic patient measures blood glucose levels several times a day to monitor and control blood sugar levels. Failure to test blood glucose levels accurately and on a regular basis can result in serious diabetes-related complications, including cardiovascular disease, kidney disease, nerve damage and blindness.
- electronic devices currently available which enable an individual to test the glucose level in a small sample of blood.
- One such glucose meter is the OneTouch® ProfileTM glucose meter, a product which is manufactured by LifeScan.
- physiological parameter(s) e.g., body temperature, cardiac rhythm, blood pressure, oxygen saturation in blood, electrocardiography, EEG, pulse, skin conductance, total hemoglobin, carboxyhemoglobin, methemoglobin, perfusion index, glucose levels, ketone, cholesterol and the like
- EEG electrocardiography
- EEG electrocardiography
- EEG electrocardiography
- skin conductance total hemoglobin
- carboxyhemoglobin methemoglobin
- perfusion index glucose levels, ketone, cholesterol and the like
- a person managing a chronic disease e.g., diabetes, asthma, high blood pressure and the like
- a buttonless physiological monitor described earlier faces the problem of accessing that person's prior physiological measurements quickly and intuitively in the absence of any user input interface (buttons, touchscreen, or voice-command and the like).
- a user input interface e.g., buttons, touch screen or non-contact touchscreen.
- a meter without a user input interface does not allow for manipulation of the temporal parameters (e.g., time, date or both time and date). Consequently, any stored physiological measurement will not have a time record or time-stamp to indicate when the physiological measurement was taken. This would render the physiological measurement records virtually worthless without the measurements being linked to the appropriate temporal parameters.
- a method of linking a time record for each physiological measurement in a physiological measurement system has a physiological meter with a microprocessor linked to a clock, memory, display and configured such that the meter is without any user input interface for a user to set temporal parameters including time for the physiological meter.
- the method can be achieved by: determining whether the clock has been reset, and if true, evaluating whether a clock reset flag has been set; if the evaluating step is false then setting a clock reset flag and setting the clock to its initial factory parameters, otherwise if the evaluating step is true then disqualifying any physiological measurement record having a delta-time flag associated with the record; if the determining step is false then querying as to whether a physiological measurement has been made; if the querying is true, ascertaining as to whether a clock reset flag has been set; if the querying is false then storing the physiological measurement linked to a record of a current temporal parameter of the clock otherwise if the querying is true then storing the physiological measurement with both a delta time flag and a current temporal parameter of the clock; verifying whether a clock reset flag is set and if the clock reset flag is not set, displaying clock time on the display of the meter otherwise if the clock reset flag is set, prohibiting a display of the clock time on the display of the meter.
- the method may further include establishing whether the meter is in communication with another or remote processor that has its own clock and if the meter is in communication with the another processor, checking if the clock reset flag is set; and if the checking returns a true then calculating a differential time between the local time clock of the remote processor and the clock of the meter and linking all stored analyte records with a differential time flag using the differential time from the calculating step, otherwise if the checking returns a false then checking to see if a temporal adjustment between the clock of the meter and the remote processor is needed.
- the determining step comprises checking for at least one internal error of the clock circuit or any circuitry of the meter; the determining step comprises checking for electrostatic discharge in the clock circuit, interruption in clock oscillation, or any fault or interruption in the circuitry of the meter; the displaying comprises a display of at least one recent physiological measurement; the prohibiting comprises a display of at least one recent physiological measurement.
- the temporal parameters comprise date and year; the analyte measurement may include a glucose measurement in a physiological fluid of the user.
- the steps disclosed may be performed by an electronic circuit or a processor. These steps may also be implemented as executable instructions stored on a computer readable medium; the instructions, when executed by a computer may perform the steps of any one of the aforementioned methods.
- each medium comprising executable instructions, which, when executed by a computer, perform the steps of any one of the aforementioned methods.
- test meters such as test meters or analyte testing devices
- each device or meter comprising an electronic circuit or processor configured to perform the steps of any one of the aforementioned methods.
- FIG. 1 illustrates a preferred blood glucose measurement system with a physiological meter and an analyte biosensor in the form of a disposable test strip.
- FIG. 2 illustrates the various components disposed in the meter of FIG. 1 .
- FIG. 3 illustrates the logic to allow for time record linkage to the physiological measurement record.
- Applicant's invention has achieved the goal of allowing persons with chronic diseases to use a very simple meter (i.e., one without any user input interface such as buttons, touch screen or voice recognition interface) with virtually none of its disadvantages when it comes to keeping track of physiological measurements for prospective or retrospective analysis of the physiological measurements. Therefore, the following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered.
- the drawings which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention.
- the detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
- the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein.
- the terms “patient,” “host,” “user,” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
- FIG. 1 illustrates a diabetes management system that includes a meter 10 and a biosensor in the form of a glucose test strip 18 .
- the meter 10 may be referred to as a physiological measurement and management unit, a glucose meter, a meter, and a physiological measurement device.
- the meter unit may be combined with an insulin delivery device, an additional analyte testing device, and a drug delivery device.
- the meter unit may be connected to a remote computer or remote server 21 via a cable (not shown) or a suitable wireless technology 20 such as, for example, GSM, CDMA, BlueTooth, WiFi and the like.
- analyte measurement meter or meter unit 10 may include a housing 12 a display 14 , and a strip port opening 16 .
- the display 12 can be configured to show the temporal parameters 14 a , physiological measurement 14 b and past recorded physiological measurements that can be presented statistically in graphical form.
- the electronic components of meter 10 may be disposed on a circuit board 34 that is within housing 12 .
- the meter 10 is shown as a blood glucose meter, other types of physiological meters can also utilize this technique devised by applicants.
- the meter can be in the form a blood pressure monitor and the physiological measurements can be blood pressure taken during different times of the day; the meter can be in the form of a pulse oximetry meter with oxygen saturation values being the physiological measurements measured at various times of the day.
- the meter may include more than one physiological monitor.
- FIG. 2 illustrates (in simplified schematic form) the electronic components disposed on a top surface of circuit board 34 .
- the electronic components include a strip port connector 22 , an operational amplifier circuit 35 , a microcontroller 38 , a display connector 14 a , a non-volatile memory 40 , a clock circuit 42 , and a first wireless module 46 .
- the electronic components may include a battery connector (not shown) and a data port 13 .
- Microcontroller 38 may be electrically connected to strip port connector 22 , operational amplifier circuit 35 , first wireless module 46 , display 14 , non-volatile memory 40 , clock 42 , battery, and data port 13 .
- Operational amplifier circuit 35 may include two or more operational amplifiers configured to provide a portion of the potentiostat function and the current measurement function.
- the potentiostat function may refer to the application of a test voltage between at least two electrodes of a test strip 18 .
- the current function may refer to the measurement of a test current resulting from the applied test voltage. The current measurement may be performed with a current-to-voltage converter.
- Microcontroller 38 may be in the form of a mixed signal microprocessor (MSP) such as, for example, the Texas Instrument MSP 430 .
- the TI-MSP 430 may be configured to also perform a portion of the potentiostat function and the current measurement function.
- the MSP 430 may also include volatile and non-volatile memory.
- many of the electronic components may be integrated with the microcontroller in the form of an application specific integrated circuit (ASIC).
- ASIC application specific integrated circuit
- Strip port connector 22 may be configured to form an electrical connection to the test strip.
- Display connector 14 a may be configured to attach to display 14 .
- Display 14 may be in the form of a liquid crystal display for reporting measured glucose levels, and for facilitating entry of lifestyle related information.
- Display 14 may optionally include a backlight.
- Data port 13 may accept a suitable connector attached to a connecting lead, thereby allowing glucose meter 10 to be linked to an external device such as a personal computer.
- Data port 13 may be any port that allows for transmission of data such as, for example, a serial, USB, or a parallel port.
- Clock 42 may be configured to keep current temporal parameter related to the geographic region in which the user is located and also for measuring time.
- the meter unit may be configured to be electrically connected to a power supply such as, for example, a battery.
- Strip 18 includes a reagent layer (typically glucose dehydrogenase (GDH) based on the PQQ co-factor and ferricyanide).
- GDH glucose dehydrogenase
- the reagent or enzyme may be replaced with the enzyme GDH based on the FAD co-factor.
- GDH (red) is regenerated back to its active oxidized state by ferricyanide (i.e. oxidized mediator or Fe (CN) 6 3 ⁇ ) as shown in chemical transformation T.2 below.
- ferrocyanide i.e. reduced mediator or Fe(CN) 6 4 ⁇
- Meter 10 may include electronic circuitry that can be used to apply a plurality of voltages to the test strip 18 and to measure a current transient output resulting from an electrochemical reaction in a test chamber of the test strip 18 .
- the signal processor 38 of meter 10 is provided with a set of instructions for the method of determining an analyte concentration in a fluid sample.
- the user inserts the test strip into a strip port connector of the test meter to connect at least two electrodes of the test strip to a strip measurement circuit.
- This turns on the meter 10 and the meter may recognize that the strip 18 has been inserted, the test meter 10 initiates a fluid detection mode. Once it has been determined that sufficient fluid amount has been deposited, the meter automatically initiate the glucose test. Details of this technique to determine sufficient volume for electrochemical testing are shown and described in U.S. Pat. Nos. 7,195,704; 6,872,298; 6,856,125; and 6,797,150, which documents are incorporated by reference as if fully set forth herein. A determination of the glucose concentration from the current transient output from the test strip 18 can be found in U.S. Pat. No. 7,749,371, patented Jul. 6, 2010, which was filed on 30 Sep., 2005 and entitled “Method and Apparatus for Rapid Electrochemical Analysis,” which is hereby incorporated by reference in its entirety into this application.
- Process 300 can be initiated whenever the meter is turned on, after a test measurement, or when connected to a remote processor, such as, for example, a personal computer, a smartphone, or a remote server 21 .
- a check is made by the microcontroller 38 whether at least one of a command to reset clock 42 or an occurrence of the clock 42 being reset has been made due to an error, command or application of power (e.g., such as during the insertion of a new battery).
- step 302 returns a true, then microcontroller 38 evaluates as to whether a clock reset flag has been set at step 304 .
- the controller 38 sets a “clock reset” flag as part of its program at step 310 and the clock 42 to its initial factory parameters at step 308 .
- the system disqualify, at step 306 any physiological measurement record having a delta-time flag associated with the analyte record.
- the clock 42 is set to its initial parameters.
- the initial parameters may include the temporal parameters provided to the system during manufacturing of the meter. This may include the initial date and time programmed into any non-erasable memory of the clock circuit.
- the phrase “disqualify” and variations on this root term means that the disqualified physiological measurement records cannot be used or shown to the user even though such records are available for purpose of diagnostics.
- the system query as to whether a physiological measurement has been made at step 312 . If the querying is true, then the system ascertains, at step 314 , as to whether a clock reset flag has been set. At step 314 , if the querying is false then the system stores the physiological measurement linked to a record of a current temporal parameter of the clock at step 318 , otherwise if the querying at step 314 is true then storing the physiological measurement with both a delta time flag and a current temporal parameter of the clock at step 316 ; verifying whether a clock reset flag is set and if the clock reset flag is not set, displaying clock time on the display of the meter otherwise if the clock reset flag is set, prohibiting a display of the clock time on the display of the meter when the physiological measurement record is reviewed.
- the annunciator is also prohibited from annunciating the temporal parameters for the physiological measurement records.
- the phrase “current temporal parameter” of the clock is intended to include at least a current time and preferably, current time, date and year.
- step 320 the system establishes at step 320 whether the meter is communication or preparing to communicate with a remote processor 21 . If step 320 returns a true then the system checks to see if a “clock reset” flag has been set at step 322 . If step 322 is true, a calculation is made at step 324 of ⁇ T where ⁇ T is a representation of a difference between the temporal parameter of the remote processor 21 versus the temporal parameter of the clock 42 of the meter. The symbol delta signifies that time stamp linked to the measurement record from one measurement to another correct relatively but not absolutely. Where the temporal parameter is in the form of hours or minutes (or even seconds), ⁇ T is a time differential between the remote processor 21 and the clock 42 .
- ⁇ T is a date differential between the remote processor 21 and the clock 42 .
- all stored physiological measurement records with the ⁇ T flag is adjusted with the calculated ⁇ T. For example, if the clock 42 is 2 hours faster than the remote processor clock then all records with the ⁇ T flag is subtracted by two hours; if the clock 42 is 4 hours slower than the remote processor clock then 4 hours are added to all records with the ⁇ T flag.
- step 328 determines if a temporal adjustment is needed for the clock 42 based on the temporal parameters of the remote processor clock. For example, at step 328 , if it is determined that the clock 42 is too fast, too slow or in a different time zone then a flag can be set or the clock 42 can be adjusted to have the same temporal parameters (e.g., time and date) as remote processor clock. This step 328 is intended to account for time drift or different time zones.
- step 320 If step 320 cannot establish that the meter is in communication with the remote processor 21 , verification is made at step 330 to determine if the clock reset flag was set. If step 330 returns a true, meaning that the clock reset flag was set, the system prohibits the meter from showing the temporal parameters (e.g., time or date) at step 332 . If step 330 returns a false, meaning that there is no clock reset flag established, then the meter is allowed to display the temporal parameters at step 334 . Both steps 332 and 334 revert to the main routine at step 336 .
- the determining step 302 may include checking for at least one internal error of the clock circuit or an error in any circuitry of the meter or the processor. Such error may include electrostatic discharge in the clock circuit or any circuitry of the meter or the meter circuit.
- the displaying of the temporal parameters may include a display of at least one recent physiological measurement.
- the prohibition of the temporal parameters may include prohibiting a display of at least one recent physiological measurement or in other words, prohibiting the display of temporal parameters when the physiological measurement value is displayed or annunciated.
- the temporal parameters comprise date and year. Additionally, the method described herein can be programmed into any suitable processor so that the steps of the method can be carried out by such processor.
- this heretofore new technique is also applicable to any physiological measurement of physiological parameters and is not limited to analyte (e.g., glucose) measurement of blood.
- analyte e.g., glucose
- the technique has advanced the state-of-the art by allowing for the technical effects of a very simple meter (i.e., one without any user input interface) with virtually none of its disadvantages when it comes to keeping track of physiological measurements for prospective or retrospective analysis of the measurements.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Databases & Information Systems (AREA)
- Medical Informatics (AREA)
- Optics & Photonics (AREA)
- Human Computer Interaction (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
- Physiological measurements can be performed with a wide variety of known physiological measurement devices. For example, body temperature, cardiac rhythm, blood pressure, oxygen saturation in blood, electrocardiography, EEG, pulse, skin conductance, total hemoglobin, carboxyhemoglobin, methemoglobin, perfusion index and the like can be monitored with small handheld instrument or meter. Similarly, physiological measurements can be made of analytes (glucose, ketone, cholesterol and the like) present in physiological fluids, e.g. blood, blood derived products, or other fluids in biological systems. Physiological detection find use in a variety of applications, including clinical laboratory testing, home testing, hospitals, clinical, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions.
- One area that applicants have concentrated is the physiological monitoring of persons with diabetes. In such person, glucose monitoring is one technique to ensure normal glycemic state of such person. The accuracy of such monitoring can significantly affect the health and ultimately the quality of life of the person with diabetes. Generally, a diabetic patient measures blood glucose levels several times a day to monitor and control blood sugar levels. Failure to test blood glucose levels accurately and on a regular basis can result in serious diabetes-related complications, including cardiovascular disease, kidney disease, nerve damage and blindness. There are a number of electronic devices currently available which enable an individual to test the glucose level in a small sample of blood. One such glucose meter is the OneTouch® Profile™ glucose meter, a product which is manufactured by LifeScan.
- There currently exist a number of portable electronic devices that can measure physiological parameter(s) (e.g., body temperature, cardiac rhythm, blood pressure, oxygen saturation in blood, electrocardiography, EEG, pulse, skin conductance, total hemoglobin, carboxyhemoglobin, methemoglobin, perfusion index, glucose levels, ketone, cholesterol and the like) in an individual and store the measurements for recalling or uploading to another computer or remote processor for analysis. These devices are provided with user input interfaces such as buttons and capacitive touchscreen to allow the user to manipulate information or configure parameters for the meter.
- It has been proposed by others in the art to utilize a buttonless physiological meter, as shown and described in U.S. Pat. No. 5,410,474, which is incorporated by reference herein. From the standpoint of the users, a meter without any button or user input interface is very attractive due to its operational simplicity. Nevertheless, such systems are susceptible to various modes of inefficiency or error.
- Applicants have recognized that a person managing a chronic disease (e.g., diabetes, asthma, high blood pressure and the like) with a buttonless physiological monitor described earlier faces the problem of accessing that person's prior physiological measurements quickly and intuitively in the absence of any user input interface (buttons, touchscreen, or voice-command and the like). For the manufacturer of such meter, there is a lower cost of manufacturing because the deletion of a user input interface (e.g., buttons, touch screen or non-contact touchscreen). However, a meter without a user input interface does not allow for manipulation of the temporal parameters (e.g., time, date or both time and date). Consequently, any stored physiological measurement will not have a time record or time-stamp to indicate when the physiological measurement was taken. This would render the physiological measurement records virtually worthless without the measurements being linked to the appropriate temporal parameters.
- In one aspect, a method of linking a time record for each physiological measurement in a physiological measurement system is provided. The system has a physiological meter with a microprocessor linked to a clock, memory, display and configured such that the meter is without any user input interface for a user to set temporal parameters including time for the physiological meter. The method can be achieved by: determining whether the clock has been reset, and if true, evaluating whether a clock reset flag has been set; if the evaluating step is false then setting a clock reset flag and setting the clock to its initial factory parameters, otherwise if the evaluating step is true then disqualifying any physiological measurement record having a delta-time flag associated with the record; if the determining step is false then querying as to whether a physiological measurement has been made; if the querying is true, ascertaining as to whether a clock reset flag has been set; if the querying is false then storing the physiological measurement linked to a record of a current temporal parameter of the clock otherwise if the querying is true then storing the physiological measurement with both a delta time flag and a current temporal parameter of the clock; verifying whether a clock reset flag is set and if the clock reset flag is not set, displaying clock time on the display of the meter otherwise if the clock reset flag is set, prohibiting a display of the clock time on the display of the meter.
- Other variations in the method are possible. For example, the method may further include establishing whether the meter is in communication with another or remote processor that has its own clock and if the meter is in communication with the another processor, checking if the clock reset flag is set; and if the checking returns a true then calculating a differential time between the local time clock of the remote processor and the clock of the meter and linking all stored analyte records with a differential time flag using the differential time from the calculating step, otherwise if the checking returns a false then checking to see if a temporal adjustment between the clock of the meter and the remote processor is needed. Alternatively, the determining step comprises checking for at least one internal error of the clock circuit or any circuitry of the meter; the determining step comprises checking for electrostatic discharge in the clock circuit, interruption in clock oscillation, or any fault or interruption in the circuitry of the meter; the displaying comprises a display of at least one recent physiological measurement; the prohibiting comprises a display of at least one recent physiological measurement. In the method, the temporal parameters comprise date and year; the analyte measurement may include a glucose measurement in a physiological fluid of the user.
- In the aforementioned aspects of the disclosure, the steps disclosed may be performed by an electronic circuit or a processor. These steps may also be implemented as executable instructions stored on a computer readable medium; the instructions, when executed by a computer may perform the steps of any one of the aforementioned methods.
- In additional aspects of the disclosure, there are computer readable media, each medium comprising executable instructions, which, when executed by a computer, perform the steps of any one of the aforementioned methods.
- In additional aspects of the disclosure, there are devices, such as test meters or analyte testing devices, each device or meter comprising an electronic circuit or processor configured to perform the steps of any one of the aforementioned methods.
- These and other embodiments, features and advantages will become apparent to those skilled in the art when taken with reference to the following more detailed description of various exemplary embodiments of the invention in conjunction with the accompanying drawings that are first briefly described.
- The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention (wherein like numerals represent like elements).
-
FIG. 1 illustrates a preferred blood glucose measurement system with a physiological meter and an analyte biosensor in the form of a disposable test strip. -
FIG. 2 illustrates the various components disposed in the meter ofFIG. 1 . -
FIG. 3 illustrates the logic to allow for time record linkage to the physiological measurement record. - Applicant's invention has achieved the goal of allowing persons with chronic diseases to use a very simple meter (i.e., one without any user input interface such as buttons, touch screen or voice recognition interface) with virtually none of its disadvantages when it comes to keeping track of physiological measurements for prospective or retrospective analysis of the physiological measurements. Therefore, the following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
- As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. In addition, as used herein, the terms “patient,” “host,” “user,” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
-
FIG. 1 illustrates a diabetes management system that includes ameter 10 and a biosensor in the form of aglucose test strip 18. Note that themeter 10 may be referred to as a physiological measurement and management unit, a glucose meter, a meter, and a physiological measurement device. In an embodiment, the meter unit may be combined with an insulin delivery device, an additional analyte testing device, and a drug delivery device. The meter unit may be connected to a remote computer orremote server 21 via a cable (not shown) or a suitablewireless technology 20 such as, for example, GSM, CDMA, BlueTooth, WiFi and the like. - Referring back to
FIG. 1 , analyte measurement meter ormeter unit 10 may include a housing 12 adisplay 14, and a strip port opening 16. Thedisplay 12 can be configured to show thetemporal parameters 14 a,physiological measurement 14 b and past recorded physiological measurements that can be presented statistically in graphical form. The electronic components ofmeter 10 may be disposed on acircuit board 34 that is withinhousing 12. Although themeter 10 is shown as a blood glucose meter, other types of physiological meters can also utilize this technique devised by applicants. For example, the meter can be in the form a blood pressure monitor and the physiological measurements can be blood pressure taken during different times of the day; the meter can be in the form of a pulse oximetry meter with oxygen saturation values being the physiological measurements measured at various times of the day. Alternatively, the meter may include more than one physiological monitor. It should be clear that the technique devised by applicants here are not limited to the few examples described herein. -
FIG. 2 illustrates (in simplified schematic form) the electronic components disposed on a top surface ofcircuit board 34. On the top surface, the electronic components include astrip port connector 22, anoperational amplifier circuit 35, amicrocontroller 38, adisplay connector 14 a, anon-volatile memory 40, aclock circuit 42, and a firstwireless module 46. On the bottom surface, the electronic components may include a battery connector (not shown) and adata port 13.Microcontroller 38 may be electrically connected tostrip port connector 22,operational amplifier circuit 35, firstwireless module 46,display 14,non-volatile memory 40,clock 42, battery, anddata port 13. -
Operational amplifier circuit 35 may include two or more operational amplifiers configured to provide a portion of the potentiostat function and the current measurement function. The potentiostat function may refer to the application of a test voltage between at least two electrodes of atest strip 18. The current function may refer to the measurement of a test current resulting from the applied test voltage. The current measurement may be performed with a current-to-voltage converter.Microcontroller 38 may be in the form of a mixed signal microprocessor (MSP) such as, for example, the Texas Instrument MSP 430. The TI-MSP 430 may be configured to also perform a portion of the potentiostat function and the current measurement function. In addition, the MSP 430 may also include volatile and non-volatile memory. In another embodiment, many of the electronic components may be integrated with the microcontroller in the form of an application specific integrated circuit (ASIC). -
Strip port connector 22 may be configured to form an electrical connection to the test strip.Display connector 14 a may be configured to attach to display 14.Display 14 may be in the form of a liquid crystal display for reporting measured glucose levels, and for facilitating entry of lifestyle related information.Display 14 may optionally include a backlight.Data port 13 may accept a suitable connector attached to a connecting lead, thereby allowingglucose meter 10 to be linked to an external device such as a personal computer.Data port 13 may be any port that allows for transmission of data such as, for example, a serial, USB, or a parallel port.Clock 42 may be configured to keep current temporal parameter related to the geographic region in which the user is located and also for measuring time. The meter unit may be configured to be electrically connected to a power supply such as, for example, a battery. -
Strip 18 includes a reagent layer (typically glucose dehydrogenase (GDH) based on the PQQ co-factor and ferricyanide). In another embodiment, the reagent or enzyme may be replaced with the enzyme GDH based on the FAD co-factor. When blood or control solution is dosed into a sample reaction chamber ofstrip 18, glucose is oxidized by GDH(ox) and in the process converts GDH(ox) to GDH(red), as shown in the chemical transformation T.1 below. Note that GDH(ox) refers to the oxidized state of GDH, and GDH(red) refers to the reduced state of GDH. -
D-Glucose+GDH(ox) Gluconic acid+GDH(red) T.1 - Next, GDH(red) is regenerated back to its active oxidized state by ferricyanide (i.e. oxidized mediator or Fe (CN)6 3−) as shown in chemical transformation T.2 below. In the process of regenerating GDH(ox), ferrocyanide (i.e. reduced mediator or Fe(CN)6 4−) is generated from the reaction as shown in T.2:
-
GDH(red)+2Fe(CN)6 3− GDH(ox)+2Fe(CN)6 4− T.2 -
Meter 10 may include electronic circuitry that can be used to apply a plurality of voltages to thetest strip 18 and to measure a current transient output resulting from an electrochemical reaction in a test chamber of thetest strip 18. Thesignal processor 38 ofmeter 10 is provided with a set of instructions for the method of determining an analyte concentration in a fluid sample. - As is known, the user inserts the test strip into a strip port connector of the test meter to connect at least two electrodes of the test strip to a strip measurement circuit. This turns on the
meter 10 and the meter may recognize that thestrip 18 has been inserted, thetest meter 10 initiates a fluid detection mode. Once it has been determined that sufficient fluid amount has been deposited, the meter automatically initiate the glucose test. Details of this technique to determine sufficient volume for electrochemical testing are shown and described in U.S. Pat. Nos. 7,195,704; 6,872,298; 6,856,125; and 6,797,150, which documents are incorporated by reference as if fully set forth herein. A determination of the glucose concentration from the current transient output from thetest strip 18 can be found in U.S. Pat. No. 7,749,371, patented Jul. 6, 2010, which was filed on 30 Sep., 2005 and entitled “Method and Apparatus for Rapid Electrochemical Analysis,” which is hereby incorporated by reference in its entirety into this application. - Referring to
FIG. 3 , applicant has devised alogical process 300 to allow for any physiological meter without a user input interface to utilize temporal parameters linked to physiological measurements and storing both the temporal parameters with the respective physiological measurements.Process 300 can be initiated whenever the meter is turned on, after a test measurement, or when connected to a remote processor, such as, for example, a personal computer, a smartphone, or aremote server 21. Atstep 302, a check is made by themicrocontroller 38 whether at least one of a command to resetclock 42 or an occurrence of theclock 42 being reset has been made due to an error, command or application of power (e.g., such as during the insertion of a new battery). Ifstep 302 returns a true, thenmicrocontroller 38 evaluates as to whether a clock reset flag has been set atstep 304. In the event the evaluatingstep 304 is false (or returning a “no”), then thecontroller 38 sets a “clock reset” flag as part of its program atstep 310 and theclock 42 to its initial factory parameters atstep 308. Otherwise if the evaluatingstep 304 is true then the system disqualify, atstep 306 any physiological measurement record having a delta-time flag associated with the analyte record. Thereafter, theclock 42 is set to its initial parameters. The initial parameters may include the temporal parameters provided to the system during manufacturing of the meter. This may include the initial date and time programmed into any non-erasable memory of the clock circuit. As used herein, the phrase “disqualify” and variations on this root term means that the disqualified physiological measurement records cannot be used or shown to the user even though such records are available for purpose of diagnostics. - If the determining
step 302 is false then the system query as to whether a physiological measurement has been made atstep 312. If the querying is true, then the system ascertains, atstep 314, as to whether a clock reset flag has been set. Atstep 314, if the querying is false then the system stores the physiological measurement linked to a record of a current temporal parameter of the clock atstep 318, otherwise if the querying atstep 314 is true then storing the physiological measurement with both a delta time flag and a current temporal parameter of the clock atstep 316; verifying whether a clock reset flag is set and if the clock reset flag is not set, displaying clock time on the display of the meter otherwise if the clock reset flag is set, prohibiting a display of the clock time on the display of the meter when the physiological measurement record is reviewed. Applicants note that where meter utilizes an audible annunciator (with or without the display), the annunciator is also prohibited from annunciating the temporal parameters for the physiological measurement records. As used herein, the phrase “current temporal parameter” of the clock is intended to include at least a current time and preferably, current time, date and year. - If the query at
step 312 returns a false then the system establishes atstep 320 whether the meter is communication or preparing to communicate with aremote processor 21. Ifstep 320 returns a true then the system checks to see if a “clock reset” flag has been set atstep 322. Ifstep 322 is true, a calculation is made atstep 324 of ΔT where ΔT is a representation of a difference between the temporal parameter of theremote processor 21 versus the temporal parameter of theclock 42 of the meter. The symbol delta signifies that time stamp linked to the measurement record from one measurement to another correct relatively but not absolutely. Where the temporal parameter is in the form of hours or minutes (or even seconds), ΔT is a time differential between theremote processor 21 and theclock 42. Alternatively, where the temporal parameter is in the form of days, ΔT is a date differential between theremote processor 21 and theclock 42. Thereafter, atstep 326, all stored physiological measurement records with the ΔT flag is adjusted with the calculated ΔT. For example, if theclock 42 is 2 hours faster than the remote processor clock then all records with the ΔT flag is subtracted by two hours; if theclock 42 is 4 hours slower than the remote processor clock then 4 hours are added to all records with the ΔT flag. - On the other hand, if the check in
step 322 returns a false, meaning that the clock reset flag is not set then a check is made atstep 328 to determine if a temporal adjustment is needed for theclock 42 based on the temporal parameters of the remote processor clock. For example, atstep 328, if it is determined that theclock 42 is too fast, too slow or in a different time zone then a flag can be set or theclock 42 can be adjusted to have the same temporal parameters (e.g., time and date) as remote processor clock. Thisstep 328 is intended to account for time drift or different time zones. - If
step 320 cannot establish that the meter is in communication with theremote processor 21, verification is made atstep 330 to determine if the clock reset flag was set. Ifstep 330 returns a true, meaning that the clock reset flag was set, the system prohibits the meter from showing the temporal parameters (e.g., time or date) atstep 332. Ifstep 330 returns a false, meaning that there is no clock reset flag established, then the meter is allowed to display the temporal parameters atstep 334. Bothsteps step 336. - In the logic devised by applicant, the determining
step 302 may include checking for at least one internal error of the clock circuit or an error in any circuitry of the meter or the processor. Such error may include electrostatic discharge in the clock circuit or any circuitry of the meter or the meter circuit. It is noted that the displaying of the temporal parameters may include a display of at least one recent physiological measurement. Alternatively, the prohibition of the temporal parameters may include prohibiting a display of at least one recent physiological measurement or in other words, prohibiting the display of temporal parameters when the physiological measurement value is displayed or annunciated. In the method, the temporal parameters comprise date and year. Additionally, the method described herein can be programmed into any suitable processor so that the steps of the method can be carried out by such processor. - Applicant notes that this heretofore new technique is also applicable to any physiological measurement of physiological parameters and is not limited to analyte (e.g., glucose) measurement of blood. Moreover, the technique has advanced the state-of-the art by allowing for the technical effects of a very simple meter (i.e., one without any user input interface) with virtually none of its disadvantages when it comes to keeping track of physiological measurements for prospective or retrospective analysis of the measurements.
- Accordingly, while the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/827,296 US9903879B2 (en) | 2013-03-14 | 2013-03-14 | Method to allow for linking temporal record with physiological measurement in buttonless physiological meters |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/827,296 US9903879B2 (en) | 2013-03-14 | 2013-03-14 | Method to allow for linking temporal record with physiological measurement in buttonless physiological meters |
Publications (2)
Publication Number | Publication Date |
---|---|
US20140269216A1 true US20140269216A1 (en) | 2014-09-18 |
US9903879B2 US9903879B2 (en) | 2018-02-27 |
Family
ID=51526573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/827,296 Active 2034-01-08 US9903879B2 (en) | 2013-03-14 | 2013-03-14 | Method to allow for linking temporal record with physiological measurement in buttonless physiological meters |
Country Status (1)
Country | Link |
---|---|
US (1) | US9903879B2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5897493A (en) * | 1997-03-28 | 1999-04-27 | Health Hero Network, Inc. | Monitoring system for remotely querying individuals |
US5410474A (en) | 1993-07-27 | 1995-04-25 | Miles Inc. | Buttonless memory system for an electronic measurement device |
US6797150B2 (en) | 2001-10-10 | 2004-09-28 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
US6872298B2 (en) | 2001-11-20 | 2005-03-29 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
US6856125B2 (en) | 2001-12-12 | 2005-02-15 | Lifescan, Inc. | Biosensor apparatus and method with sample type and volume detection |
US7749371B2 (en) | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
-
2013
- 2013-03-14 US US13/827,296 patent/US9903879B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9903879B2 (en) | 2018-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101722417B1 (en) | Analyte testing method and system with high and low blood glucose trends notification | |
US20140024907A1 (en) | Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes | |
EP2554110B1 (en) | Analyte testing method and system | |
US9592002B2 (en) | Method and system to derive multiple glycemic patterns from glucose measurements during time of the day | |
JP5795368B2 (en) | Method, system and apparatus for ensuring statistical power for message display of average pre-meal and post-meal glucose differences | |
US20140074059A1 (en) | Method and system to indicate glycemic impacts of insulin infusion pump commands | |
US20120165639A1 (en) | Storage of calibration data at a continuous glucose monitor | |
US20170242967A1 (en) | Display with iconic markers for a meter | |
CN105377121A (en) | Insertion site decision support system and method | |
JP2022509742A (en) | Measurement of elevated levels of circulating ketone bodies in physiological fluids | |
AU2019204351A1 (en) | Analyte-measurement system recording user menu choices | |
US20140275903A1 (en) | System and method for quick-access physiological measurement history | |
US20150044650A1 (en) | Positive reinforcement messages to users based on analytics of prior physiological measurements | |
EP3169233B1 (en) | A method and a device for determining a body fluid glucose level of a patient, and a computer program product | |
US9903879B2 (en) | Method to allow for linking temporal record with physiological measurement in buttonless physiological meters | |
EP3300656A1 (en) | Method and system for determining a carbohydrate intake event from glucose monitoring data indicative of a glucose level, and a non-transitory computer readable medium | |
AU2011273189B8 (en) | Methods to ensure statistical power for average pre and post - prandial glucose difference messaging | |
KR20130097145A (en) | Methods to ensure statistical power for average pre and post-prandial glucose difference messaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LIFESCAN SCOTLAND LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELDER, DAVID;REEL/FRAME:031211/0351 Effective date: 20130916 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, NORTH CAROLINA Free format text: SECURITY AGREEMENT;ASSIGNOR:LIFESCAN IP HOLDINGS, LLC;REEL/FRAME:047179/0150 Effective date: 20181001 Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, NORTH Free format text: SECURITY AGREEMENT;ASSIGNOR:LIFESCAN IP HOLDINGS, LLC;REEL/FRAME:047179/0150 Effective date: 20181001 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, NORTH CAROLINA Free format text: SECURITY AGREEMENT;ASSIGNOR:LIFESCAN IP HOLDINGS, LLC;REEL/FRAME:047186/0836 Effective date: 20181001 Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, NORTH Free format text: SECURITY AGREEMENT;ASSIGNOR:LIFESCAN IP HOLDINGS, LLC;REEL/FRAME:047186/0836 Effective date: 20181001 |
|
AS | Assignment |
Owner name: CILAG GMBH INTERNATIONAL, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIFESCAN SCOTLAND LTD.;REEL/FRAME:050839/0634 Effective date: 20181001 Owner name: LIFESCAN IP HOLDINGS, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CILAG GMBH INTERNATIONAL;REEL/FRAME:050840/0006 Effective date: 20181001 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
AS | Assignment |
Owner name: CILAG GMBH INTERNATIONAL, SWITZERLAND Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:LIFESCAN SCOTLAND LTD.;REEL/FRAME:064656/0141 Effective date: 20181001 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., NORTH CAROLINA Free format text: FIRST LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:LIFESCAN IP HOLDINGS, LLC;REEL/FRAME:063712/0430 Effective date: 20230519 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., NORTH CAROLINA Free format text: SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:LIFESCAN IP HOLDINGS, LLC;REEL/FRAME:063740/0080 Effective date: 20230519 |
|
AS | Assignment |
Owner name: JOHNSON & JOHNSON CONSUMER INC., NEW JERSEY Free format text: RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:064206/0176 Effective date: 20230627 Owner name: JANSSEN BIOTECH, INC., PENNSYLVANIA Free format text: RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:064206/0176 Effective date: 20230627 Owner name: LIFESCAN IP HOLDINGS, LLC, CALIFORNIA Free format text: RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:064206/0176 Effective date: 20230627 |